The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious …

JS Bradley, CL Byington, SS Shah… - Clinical infectious …, 2011 - academic.oup.com
Evidenced-based guidelines for management of infants and children with community-
acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and …

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention

JP Lynch, GG Zhanel - Seminars in respiratory and critical care …, 2009 - thieme-connect.com
Streptococcus pneumoniae is the most common cause of community-acquired pneumonia,
meningitis, and bacteremia in children and adults. Invasive pneumococcal disease (IPD) …

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

T Pilishvili, C Lexau, MM Farley, J Hadler… - The Journal of …, 2010 - academic.oup.com
Background Changes in invasive pneumococcal disease (IPD) incidence were evaluated
after 7 years of 7-valent pneumococcal conjugate vaccine (PCV7) use in US children …

Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine

SL Kaplan, WJ Barson, PL Lin, JR Romero… - The Pediatric …, 2013 - journals.lww.com
Background: The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced for
routine administration to infants and children in 2010 in the United States. We have …

Emergence of parapneumonic empyema in the USA

CG Grijalva, Y Zhu, JP Nuorti, MR Griffin - Thorax, 2011 - thorax.bmj.com
Background Although recent reports suggest that the incidence of parapneumonic empyema
has increased in several regions of the USA, national trends in disease burden are …

Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine …

RJ Singleton, TW Hennessy, LR Bulkow, LL Hammitt… - Jama, 2007 - jamanetwork.com
ContextWith routine childhood vaccination using heptavalent pneumococcal conjugate
vaccine, one concern has been the potential for emergence and expansion of replacement …

[PDF][PDF] Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance

JY Song, MH Nahm… - Journal of Korean medical …, 2013 - synapse.koreamed.org
Streptococcus pneumoniae can asymptomatically colonize the nasopharynx and cause a
diverse range of illnesses. This clinical spectrum from colonization to invasive …

Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States

CG Grijalva, JP Nuorti, Y Zhu… - Clinical Infectious …, 2010 - academic.oup.com
Background. The incidence of childhood pneumonia decreased following introduction of 7-
valent pneumococcal conjugate vaccine (PCV7) in the United States. Recent regional …

Empyema: an increasing concern in Canada

C Finley, J Clifton, JM FitzGerald… - Canadian respiratory …, 2008 - Wiley Online Library
BACKGROUND: Empyema is a suppurative infection of the pleural space. Without prompt
treatment, it can result in significant hospital stays, more invasive treatments as it …

Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine

STT Li, DJ Tancredi - Pediatrics, 2010 - publications.aap.org
OBJECTIVE: To determine if the incidence of empyema among children in the United States
has changed since the introduction of the pneumococcal conjugate vaccine in 2000 …